The Europe Microcarriers Market would witness market growth of 11.6% CAGR during the forecast period (2022-2028).
With larger cell density and, eventually, higher product yields, attachment-dependent cells are frequently cultured on a large scale using microcarriers. The quality of the result in these procedures can be impacted by the particular culture conditions, which is strongly tied to the pattern of glycosylation on the product.
Furthermore, the dearth of research in the field highlights the importance of knowing more about how microcarrier culture affects product glycosylation. As a result, the glycosylation profile of a monoclonal antibody (mAb) made by adherent CHO-K1 cells cultured in Cytodex 3 was assessed under various conditions and compared to that obtained from conventional adherent cultures in this study.
The glycosylation profile of microcarrier cultures was shown to differ from that of T-flask cultures, with a general rise in galactosylation and a decrease in fucosylation levels, both of which may have a beneficial effect on mAb activity.
The UK has done a lot of research and development in biotechnology. This is mostly due to a shift toward using live model systems for drug development and evaluation, using animal-derived component-free media & reagents, and an increasing need for advanced biologics and bio-similars made by biopharmaceutical manufacturers. This has helped technologies like 3D cell culture grow. Cell culture processes & systems are becoming more and more automated because there is a growing need for improvements in cell culture equipment and supplies in order to make biopharmaceutical production more efficient and research more reliable.
The Germany market dominated the Europe Microcarriers Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $163.1 million by 2028.The UK market is anticipated to grow a CAGR of 10.7% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 12.5% during (2022 - 2028).
Based on Consumables, the market is segmented into Microcarrier Beads and Media & Reagents. Based on Microcarrier Beads Type, the market is segmented into, Collagen Coated Beads, Cationic Beads, Protein Coated Beads, Untreated Beads and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations and Academic & Research Institutes. Based on Application, the market is segmented into Biopharmaceutical Production and Regenerative Medicine. Based on Biopharmaceutical Production Type, the market is segmented into Vaccine Production and Therapeutic Production. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Microcarriers Market will Hit $2.4 Billion by 2028, at a CAGR of 11.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Sartorius Stedim Biotech S.A. (Sartorius AG), Corning Incorporated, Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf SE, HiMedia Laboratories Pvt. Ltd., and denovoMATRIX GmbH.
By Consumables
By End User
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
